Confirmatory Adaptive Designs for Clinical Trials With Multiple Time-to-Event Outcomes in Multi-state Markov Models

被引：0
|
作者：
Danzer, Moritz Fabian [1 ]
Faldum, Andreas [1 ]
Simon, Thorsten [2 ]
Hero, Barbara [2 ]
Schmidt, Rene [1 ]
机构：
[1] Institute of Biostatistics and Clinical Research, University of Münster, Münster, Germany
[2] Department of Pediatric Oncology and Hematology, University Hospital Cologne, Cologne, Germany
来源：
Biometrical Journal | / 66卷 / 07期
关键词：
Compilation and indexing terms; Copyright 2025 Elsevier Inc;
D O I：
e202300181
中图分类号：
学科分类号：
摘要：
Disease control
引用
收藏
相关论文
共 50 条
  • [41] Joint models with multiple longitudinal outcomes and a time-to-event outcome: a corrected two-stage approach
    Mauff, Katya
    Steyerberg, Ewout
    Kardys, Isabella
    Boersma, Eric
    Rizopoulos, Dimitris
    STATISTICS AND COMPUTING, 2020, 30 (04) : 999 - 1014
  • [42] Joint models with multiple longitudinal outcomes and a time-to-event outcome: a corrected two-stage approach
    Katya Mauff
    Ewout Steyerberg
    Isabella Kardys
    Eric Boersma
    Dimitris Rizopoulos
    Statistics and Computing, 2020, 30 : 999 - 1014
  • [43] SURVIVAL ANALYSIS WITH COVARIATES IN COMBINATION WITH MULTINOMIAL ANALYSIS TO PARAMETRIZE TIME TO EVENT FOR MULTI-STATE MODELS
    Feenstra, T. L.
    Postmus, D.
    Quik, E. H.
    Langendijk, H.
    Krabbe, P. F. M.
    VALUE IN HEALTH, 2013, 16 (07) : A593 - A593
  • [44] Biomarker-Defined Subgroup Selection Adaptive Design for Phase III Confirmatory Trial with Time-to-Event Data: Comparing Group Sequential and Various Adaptive Enrichment Designs
    Tang R.
    Ma X.
    Yang H.
    Wolf M.
    Statistics in Biosciences, 2018, 10 (2) : 371 - 404
  • [45] Competing risks multi-state model for time-to-event data analysis of HIV/AIDS: a retrospective cohort national datasets, Ethiopia
    Kumssa, Tsegaye H.
    Mulu, Andargachew
    Mihret, Adane
    Asfaw, Zeytu G.
    BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [46] Counterfactual mediation analysis in the multistate model framework for surrogate and clinical time-to-event outcomes in randomized controlled trials
    Weir, Isabelle R.
    Rider, Jennifer R.
    Trinquart, Ludovic
    PHARMACEUTICAL STATISTICS, 2022, 21 (01) : 163 - 175
  • [47] Hybridization of conditional and predictive power for futility assessment in sequential clinical trials with time-to-event outcomes: A resampling approach
    Yi, Jing
    Fang, Liang
    Su, Zheng
    CONTEMPORARY CLINICAL TRIALS, 2012, 33 (01) : 138 - 142
  • [48] Demonstration of Group-Level and Individual-Level Efficacy Using Time-to-Event Designs for Clinical Trials of Antiseizure Medications
    Kerr, Wesley T.
    Kok, Neo
    Reddy, Advith S.
    McFarlane, Katherine N.
    Stern, John M.
    Pennell, Page B.
    Stacey, William
    French, Jacqueline
    NEUROLOGY, 2024, 103 (04)
  • [49] Knee Injury and Transitions Among States of Knee Osteoarthritis in the Johnston County Osteoarthritis Project: A Multi-State Time-To-Event Modeling Approach
    Golightly, Yvonne
    Alvarez, Carolina
    Arbeeva, Liubov
    Cleveland, Rebecca
    Schwartz, Todd
    Murphy, Louise
    Renner, Jordan
    Callahan, Leigh
    Jordan, Joanne
    Nelson, Amanda
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [50] Profiling Delirium Progression in Elderly Patients via Continuous-Time Markov Multi-State Transition Models
    Ocagli, Honoria
    Azzolina, Danila
    Soltanmohammadi, Rozita
    Aliyari, Roqaye
    Bottigliengo, Daniele
    Acar, Aslihan Senturk
    Stivanello, Lucia
    Degan, Mario
    Baldi, Ileana
    Lorenzoni, Giulia
    Gregori, Dario
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (06):
12345